The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Epizyme, Inc. | Common Stock | 29428V104 | 19,651 | 3,838,166 | SH | SOLE | 3,838,166 | 0 | 0 | ||
| Progyny, Inc. | Common Stock | 74340E103 | 414,742 | 7,406,115 | SH | SOLE | 7,406,115 | 0 | 0 | ||
| Pulmonx Corporation | Common Stock | 745848101 | 35,799 | 994,971 | SH | SOLE | 994,971 | 0 | 0 | ||
| Rapid Micro Biosystems, Inc. | Common Stock | 75340L104 | 598 | 32,400 | SH | SOLE | 32,400 | 0 | 0 | ||
| TransMedics Group, Inc. | Common Stock | 89377M109 | 30,549 | 923,221 | SH | SOLE | 923,221 | 0 | 0 | ||